(HCKT) The Hackett - Overview
Stock: Benchmarking, Consulting, Oracle, SAP, Research
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.14% |
| Yield on Cost 5y | 3.61% |
| Yield CAGR 5y | 4.66% |
| Payout Consistency | 97.3% |
| Payout Ratio | 41.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.4% |
| Relative Tail Risk | -8.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.24 |
| Alpha | -59.63 |
| Character TTM | |
|---|---|
| Beta | 0.637 |
| Beta Downside | 0.651 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.16% |
| CAGR/Max DD | -0.16 |
Description: HCKT The Hackett December 25, 2025
The Hackett Group (NASDAQ:HCKT) is a Miami-based consulting firm that leverages an intellectual-property platform and generative AI to deliver strategic advisory, benchmarking, and digital-transformation services to large enterprises across the United States, Europe, and other regions.
Its flagship offering, Hackett Connect, aggregates practice-level performance metrics, research, and best-practice accelerators, while Advisor Inquiry provides fact-based guidance on proven processes. The firm also runs peer-interaction programs (webcasts, conferences, member forums) and has expanded into AI-driven content and vendor-centric IP services.
Financially, Hackett reported FY 2023 revenue of roughly **$1.2 billion**, up **~5 % YoY**, with an operating margin near **13 %** and a cash conversion ratio of **1.2×**. The balance sheet remains strong, featuring **$450 million** of cash and no material debt, which gives the company flexibility to invest in AI capabilities and pursue strategic acquisitions.
Key sector drivers include accelerating corporate spend on **generative AI and cloud-based ERP modernization**, which the firm taps through its Oracle and SAP implementation services. Additionally, macro-level pressure on cost-of-goods-sold and the need for **benchmark-driven efficiency gains** in G&A functions support demand for Hackett’s benchmarking and shared-services assessments.
For a deeper, data-rich view of Hackett’s valuation dynamics, you might explore the company’s profile on ValueRay, which aggregates analyst estimates and peer comparisons in a single dashboard.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 10.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA -8.10 > 1.0 |
| NWC/Revenue: 12.24% < 20% (prev 8.26%; Δ 3.98% < -1%) |
| CFO/TA 0.21 > 3% & CFO 41.9m > Net Income 10.9m |
| Net Debt (32.6m) to EBITDA (27.0m): 1.21 < 3 |
| Current Ratio: 1.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.6m) vs 12m ago -1.87% < -2% |
| Gross Margin: 37.90% > 18% (prev 0.39%; Δ 3750 % > 0.5%) |
| Asset Turnover: 157.5% > 50% (prev 161.0%; Δ -3.49% > 0%) |
| Interest Coverage Ratio: 17.79 > 6 (EBITDA TTM 27.0m / Interest Expense TTM 1.25m) |
Altman Z'' 3.89
| A: 0.19 (Total Current Assets 80.4m - Total Current Liabilities 42.7m) / Total Assets 200.7m |
| B: 0.38 (Retained Earnings 75.8m / Total Assets 200.7m) |
| C: 0.11 (EBIT TTM 22.2m / Avg Total Assets 195.7m) |
| D: 0.64 (Book Value of Equity 62.9m / Total Liabilities 99.0m) |
| Altman-Z'' Score: 3.89 = AA |
Beneish M -3.22
| DSRI: 0.93 (Receivables 57.3m/61.2m, Revenue 308.2m/307.0m) |
| GMI: 1.04 (GM 37.90% / 39.49%) |
| AQI: 0.97 (AQ_t 0.47 / AQ_t-1 0.49) |
| SGI: 1.00 (Revenue 308.2m / 307.0m) |
| TATA: -0.15 (NI 10.9m - CFO 41.9m) / TA 200.7m) |
| Beneish M-Score: -3.22 (Cap -4..+1) = AA |
What is the price of HCKT shares?
Over the past week, the price has changed by -11.40%, over one month by -19.19%, over three months by -13.33% and over the past year by -48.34%.
Is HCKT a buy, sell or hold?
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HCKT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.3 | 75.2% |
| Analysts Target Price | 28.3 | 75.2% |
| ValueRay Target Price | 14.6 | -9.8% |
HCKT Fundamental Data Overview February 05, 2026
P/E Forward = 10.6157
P/S = 1.5233
P/B = 4.5074
P/EG = 0.9646
Revenue TTM = 308.2m USD
EBIT TTM = 22.2m USD
EBITDA TTM = 27.0m USD
Long Term Debt = 43.8m USD (from longTermDebt, last quarter)
Short Term Debt = 1.18m USD (from shortTermDebt, last quarter)
Debt = 46.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.6m USD (from netDebt column, last quarter)
Enterprise Value = 494.9m USD (462.3m + Debt 46.5m - CCE 13.9m)
Interest Coverage Ratio = 17.79 (Ebit TTM 22.2m / Interest Expense TTM 1.25m)
EV/FCF = 14.14x (Enterprise Value 494.9m / FCF TTM 35.0m)
FCF Yield = 7.07% (FCF TTM 35.0m / Enterprise Value 494.9m)
FCF Margin = 11.36% (FCF TTM 35.0m / Revenue TTM 308.2m)
Net Margin = 3.54% (Net Income TTM 10.9m / Revenue TTM 308.2m)
Gross Margin = 37.90% ((Revenue TTM 308.2m - Cost of Revenue TTM 191.4m) / Revenue TTM)
Gross Margin QoQ = 41.20% (prev 35.43%)
Tobins Q-Ratio = 2.47 (Enterprise Value 494.9m / Total Assets 200.7m)
Interest Expense / Debt = 0.94% (Interest Expense 438.0k / Debt 46.5m)
Taxrate = 49.27% (2.47m / 5.02m)
NOPAT = 11.3m (EBIT 22.2m * (1 - 49.27%))
Current Ratio = 1.88 (Total Current Assets 80.4m / Total Current Liabilities 42.7m)
Debt / Equity = 0.46 (Debt 46.5m / totalStockholderEquity, last quarter 101.6m)
Debt / EBITDA = 1.21 (Net Debt 32.6m / EBITDA 27.0m)
Debt / FCF = 0.93 (Net Debt 32.6m / FCF TTM 35.0m)
Total Stockholder Equity = 112.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.58% (Net Income 10.9m / Total Assets 200.7m)
RoE = 9.67% (Net Income TTM 10.9m / Total Stockholder Equity 112.9m)
RoCE = 14.17% (EBIT 22.2m / Capital Employed (Equity 112.9m + L.T.Debt 43.8m))
RoIC = 8.21% (NOPAT 11.3m / Invested Capital 137.1m)
WACC = 7.55% (E(462.3m)/V(508.8m) * Re(8.26%) + D(46.5m)/V(508.8m) * Rd(0.94%) * (1-Tc(0.49)))
Discount Rate = 8.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.53%
[DCF Debug] Terminal Value 79.40% ; FCFF base≈40.5m ; Y1≈39.4m ; Y5≈39.5m
Fair Price DCF = 29.18 (EV 764.9m - Net Debt 32.6m = Equity 732.3m / Shares 25.1m; r=7.55% [WACC]; 5y FCF grow -3.79% → 2.90% )
EPS Correlation: 54.68 | EPS CAGR: 3.10% | SUE: 0.0 | # QB: 0
Revenue Correlation: 53.03 | Revenue CAGR: 0.73% | SUE: -0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.38 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=1.69 | Chg30d=+0.027 | Revisions Net=+1 | Growth EPS=+10.0% | Growth Revenue=-0.9%